These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2110053)

  • 1. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual coronary stenoses and calculated transstenotic gradients after intravenous streptokinase versus tissue plasminogen activator.
    Kimball BP; Bui S; Ling A; Dafopoulos N
    Am Heart J; 1992 Jan; 123(1):7-14. PubMed ID: 1729852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy in selected patients with impending myocardial reinfarction.
    Mendia R; Negrini M; Turazza FM; Lazzaroni A; Palmeri NM; Sanna G
    Coron Artery Dis; 1993 Jul; 4(7):631-6. PubMed ID: 8281367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic thrombolysis for early intracoronary stent thrombosis.
    Fruhwald FM; Luha O; Eber B; Schumacher M; Zweiker R; Klein W
    Lancet; 1995 Jul; 346(8967):119-20. PubMed ID: 7603192
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary thrombolysis.
    Thomas P; Sheridan DJ
    Q J Med; 1988 Sep; 68(257):657-63. PubMed ID: 2978484
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    Fresco C
    Lancet; 2003 Apr; 361(9365):1303; author reply 1304-5. PubMed ID: 12699989
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
    Weaver WD; Simes RJ; Betriu A; Grines CL; Zijlstra F; Garcia E; Grinfeld L; Gibbons RJ; Ribeiro EE; DeWood MA; Ribichini F
    JAMA; 1997 Dec; 278(23):2093-8. PubMed ID: 9403425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty.
    Verna E; Repetto S; Boscarini M; Onofri M; Qing LG; Binaghi G
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):116-22. PubMed ID: 2106394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion.
    Becker RC
    Clin Cardiol; 1994 Jan; 17(1):3-13. PubMed ID: 8149679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed coronary angioplasty after thrombolytic therapy for acute myocardial infarction.
    Little T; Lee K; Mukherjee D; Milner M; Lindsay J; Pichard AD
    Am J Cardiol; 1990 Nov; 66(17):1259-60. PubMed ID: 2122706
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention.
    Kim JS; Kim JH; Jang HH; Lee YW; Song SG; Park JH; Chun KJ
    J Atheroscler Thromb; 2010 Jul; 17(7):768-70. PubMed ID: 20467185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary thrombolysis.
    Ann Intern Med; 1990 Jul; 113(2):171. PubMed ID: 2113785
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.